Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02209532 · ClinicalTrials.gov registry record · NA
A Study Assessing the Safety and Utility of PINPOINT® Near Infrared Fluorescence Imaging in the Identification of Lymph Nodes in Patients With Uterine and Cervical Malignancies Who Are Undergoing Lymph Node Mapping
A NA study of Endometrial Cancer and Cervical Cancer, sponsored by Novadaq Technologies ULC, now a part of Stryker.
- Completed
- Registry status
- NA
- Development phase
- 180
- Enrollment target
- 8
- Study locations
NCT02209532: Completed NA study of Endometrial Cancer and Cervical Cancer, sponsored by Novadaq Technologies ULC, now a part of Stryker.
NCT02209532 is a NA study of Endometrial Cancer and Cervical Cancer that has completed, run by Novadaq Technologies ULC, now a part of Stryker. The registered enrollment target is 180 participants, below the 523-participant average among 181 other Endometrial Cancer trials with a reported enrollment target (66% lower). The trial reports 8 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02209532, a NA study of Endometrial Cancer and Cervical Cancer, has completed, sponsored by Novadaq Technologies ULC, now a part of Stryker.
- COMPLETED
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
- 8
- Study locations
Study Summary
This is a randomized, prospective, open label, multicenter study to assess the safety and utility of PINPOINT® Near Infrared Fluorescence Imaging (PINPOINT) in identification of lymph nodes (LN) in patients with uterine and cervical malignancies who are undergoing LN mapping.
Primary Outcome
To assess the effectiveness of intraoperative PINPOINT Near Infrared Fluorescence Imaging in the identification of lymph nodes in subjects with uterine and cervical malignancies who are undergoing lymph node mapping.
Conditions Studied
Interventions
- DEVICE PINPOINT
Study Locations (8)
California
- O'Connor Hospital - San Jose
Florida
- Lee Memorial Hospital - Fort Myers
New York
- Memorial Sloan Kettering - New York
North Carolina
- Duke Cancer Institute - Durham
Texas
- MD Anderson Cancer Center - Houston
Ontario
- Sunnybrook Health Science Centre - Toronto
Quebec
- CHU de Québec - Université Laval - Québec
Other
- Hospital HIMA San Pablo - Caguas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2015-12 |
| Est. Completion | 2017-06 |
| Phase | NA |
What the finished NCT02209532 record still lists
NCT02209532 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 523-participant average among 181 other Endometrial Cancer trials with a reported enrollment target (66% lower).
The record links to 3 conditions, with Endometrial Cancer appearing as the primary indexed condition, and to 1 intervention - of which PINPOINT is the first listed.
NCT02209532 lists 8 locations in 8 states (California, Florida, New York).
Frequently Asked Questions
What is clinical trial NCT02209532 about?
NCT02209532 is a clinical study titled "A Study Assessing the Safety and Utility of PINPOINT® Near Infrared Fluorescence Imaging in the Identification of Lymph Nodes in Patients With Uterine and Cervical Malignancies Who Are Undergoing Lymph Node Mapping". This is a randomized, prospective, open label, multicenter study to assess the safety and utility of PINPOINT® Near Infrared Fluorescence Imaging (PINPOINT) in identification of lymph nodes (LN) in patients with uterine and cervical malignancies who are undergoing LN mapping.
What is the current status of trial NCT02209532?
This trial is currently completed. It is a NA study. The enrollment target is 180 participants. The study started on 2015-12. Estimated completion is 2017-06.
What conditions does trial NCT02209532 study?
This clinical trial studies the following conditions: Endometrial Cancer, Cervical Cancer, Uterine Cancer.
What interventions are being tested in trial NCT02209532?
The interventions under investigation include: PINPOINT (DEVICE).
Who is sponsoring clinical trial NCT02209532?
This trial is sponsored by Novadaq Technologies ULC, now a part of Stryker, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02209532 being conducted?
This trial has 8 study locations across California, Florida, New York, North Carolina, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Endometrial Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02209532's enrollment target sits among peer trials
180 73rd of 181 higher than 108 of 181 other Endometrial Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Endometrial Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
ASk Questions in GYnecologic Oncology (ASQ-GYO)
RECRUITING · NA
-
MCC-24-GYN-11: Comparison of Nodal Sampling in Endometrial Cancer
RECRUITING · NA
-
Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)
RECRUITING · NA
-
A Study of Multiparametric Ultrasound Imaging (mpUS) for People With Endometrial Cancer
RECRUITING · NA
-
ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer
RECRUITING · NA
-
Use of an Intrauterine Manipulator and Its Correlation with Positive Peritoneal Cytology in Early Stage Endometrial Cancers
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia